Viewing Study NCT03038256

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-01-04 @ 7:57 AM
Study NCT ID: NCT03038256
Status: UNKNOWN
Last Update Posted: 2023-03-22
First Post: 2017-01-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial
Sponsor: Peking University People's Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rectal Cancer View
None Pathological Complete Response View
None Disease Free Survival View
Keywords:

Keywords

Keyword Brief Keyword Text View
None High Risk Rectal Cancer View
None Total neoadjuvant chemoradiotherapy View
None Lengthening interval between radiotherapy and surgery View